FIND A BIOALPS ACTOR
blur-business-close-up-287227

AMAL Therapeutics raises 33.2 million dollars

15.11.2018
Share this article
The Geneva-based startup just announced the completion of its Series B financing round, raising in total CHF 33.2 million.

Read Venturelab‘s interview of AMAL Therapeutics‘ CEO and Founder, Madiha Derouazi

Link to interview